drugset / Trial / NCT01064440
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate whether intramuscular injections of VM202 into the calf is safe and effective in the treatment of critical limb ischemia.
Timeline
- Start
- 2010-07-09
- Primary completion
- 2013-08-05
- Completion
- 2023-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VM202 | Other / unclassified | 8 mg | Intramuscular |
| Subject | VM202 | Other / unclassified | 16 mg | Intramuscular |